2018 Meeting Programme


10:00 – 10:30 Registration and Coffee
10:30 – 10:35 Welcome and Introduction Professor Neil Poulter and Professor Kausik Ray, Imperial College London
10:35 – 11:00 CVD prevention in DM – The importance of BP lowering Professor Neil Poulter
Imperial College London
11:00 – 11:30 The role of SGLT2s: Trial evidence and future prospects Professor Kausik Ray
Imperial College London
11:30 – 12:00 The role of GLP1-As: Trial evidence and future prospects Professor Miles Fisher
Glasgow Royal Infirmary
12:00 – 12:30 The role of other glucose lowering therapies: Trial evidence and future prospects Professor Clifford J Bailey
Aston University
12:30 – 13:00 Renal outcomes in glucose-lowering trials Professor David Wheeler
University College London
13:00 – 13:40 Lunch



13:40 – 14:10 Hypoglycaemia and CVD Dr Mark Evans
University of Cambridge
14:10 – 14:30 Breakout groups (8-10 people per group)

a. Treatment pathway for optimising 2ry prevention of CV events in T2DM
b. Optimal BP management in T2DM/CKD/Post CV events. Targets/thresholds/drugs?
c. Optimal drug sequencing for glucose lowering

14:30 – 15:15 Groups Feedback
15:15 – 15:45 Heart failure and T2DM Professor Theresa A McDonagh
King’s College London
15:45 – 16:15 Lipid lowering for optimal CVD prevention Professor Kausik Ray
Imperial College London
16:15 – 17:00 Keynote lecture
Cardiometabolic disease: burden and management
Professor David Wood
Imperial College London
17:00 – 18:00 Close of meeting and refreshments

*Please note, this Programme is correct as of 14.09.18 and is subject to changes.

Find out more

About the Meeting

We explored the latest techniques and developments in cardio-metabolic science.


The invited faculty delivered an innovative, comprehensive and educational programme.


The Meeting took place at Imperial College's Translation and Innovation Hub.